Navigation Links
VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009
Date:11/4/2009

al results to differ materially from current expectations include, but are not limited to:

  • our ability to comply with the NASDAQ rules for continued listing in order to maintain the listing of our common stock on NASDAQ;
  • our ability to obtain necessary financing in the near term, including amounts necessary to repay the loan from Bay City Capital by the December 31, 2009 maturity date (or earlier if certain repayment acceleration provisions are triggered);
  • our ability to control our operating expenses;
  • our ability to comply with covenants included in the loan from Bay City Capital;
  • our ability to timely recruit and enroll patients in any future clinical trials;
  • our failure to obtain sufficient data from enrolled patients that can be used to evaluate VIA-2291, thereby impairing the validity or statistical significance of our clinical trials;
  • our ability to successfully complete our clinical trials of VIA-2291 on expected timetables and the outcomes of such clinical trials;
  • complexities in designing and implementing cardiometabolic clinical trials using surrogate endpoints in Phase 1 and Phase 2 clinical trials which may differ from the ultimate endpoints required for registration of a candidate drug;
  • the results of our clinical trials, including without limitation, with respect to the safety and efficacy of VIA-2291;
  • if the results of the ACS and CEA studies, upon further review and analysis, are revised, interpreted differently by regulatory authorities or negated by later stage clinical trials;
  • our ability to obtain necessary FDA approvals, including to initiate future clinical trials of VIA-2291;
  • our ability to successfully commercialize VIA-2291;
  • our ability to identify potential clinical candidates from the family of DGAT1 compounds licensed and move them into preclinical development;
  • our ability to obtain and protect our intellectual prope
    '/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Reportlinker Adds Gastrointestinal Pharmaceuticals: Technologies and Markets
2. Peregrine Pharmaceuticals Regains Full Compliance With Nasdaq Continued Listing Requirements
3. Isis Pharmaceuticals to Present at the 2009 Canaccord Adams Cardiovascular Conference
4. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
5. Quark Pharmaceuticals to Present Data on its siRNA Therapeutic Programs in Kidney and Lung Diseases
6. Warner Chilcott Completes Acquisition of P&Gs Global Branded Prescription Pharmaceuticals Business
7. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
8. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
9. China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS
10. Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance
11. Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., , SAN DIEGO, Dec. 1 /PRNewswire-FirstC... ANX ) today announced that a new, recently compl...ence and comparable toxicity of ANX-514 and Taxote... ADVENTRX,s partner for ANX-514 in South Korea, in... ,, "Our independent confirmation of the bioe...
(Date:12/1/2009)..., , ROCKVILLE, Md., Dec. 1 /PRNewswire-F...VNDA ) announced today that the waiting period has...st Improvements Act of 1976 with respect to Vanda,... Pharma AG, and that the agreement is now effectiv...lting effectiveness of the agreement, triggers an ...
(Date:12/1/2009)..., , BOSTON, Dec. 1 /PRNewswire-Fi...orporation (Nasdaq: PRXL ), a leading global biop... discussion on innovative approaches to drug devel...als Asia Pacific Conference, being held December 1...e. PAREXEL is a sponsor of the conference, which i...
Breaking Medicine Technology:ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 2ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 3PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 2PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 3PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 4Cars Are No Place for Kids to Be Alone 51940 1Cars Are No Place for Kids to Be Alone 51940 2Blacks Have Highest Obesity Rates in U S 51937 1Blacks Have Highest Obesity Rates in U S 51937 2Blacks Have Highest Obesity Rates in U S 51937 3Arcadian Chairman and Chief Executive Officer Robert Fahlman to Present at Focus on Healthcare Conference in New York City 51935 1Arcadian Chairman and Chief Executive Officer Robert Fahlman to Present at Focus on Healthcare Conference in New York City 51935 2
...laboration to Focus on the Development of MicroRNA...,s Health Indications, REHOVOT, Israel and JERSEY... (Nasdaq: ROSG ), announced,today a collaboration...p,microRNA-based diagnostics in the fields of onco...n will leverage microRNAs, significant,potential a...
... ARBOR, Mich., June 25 Terumo Heart, Inc. announc...ard (IRB) at the University,of Michigan to move fo...st,System (LVAS) U.S. Pivotal Trial for a Bridge-t...., Ph.D., Director of the Adult Heart,Transplantat...ty of,Michigan, will serve as the National Co-Prin...
Other Medicine Technology:Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics 2Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics 3Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics 4Terumo Heart Obtains IRB Approval from the University of Michigan to Initiate DuraHeart(TM) Left Ventricular Assist System U.S. Pivotal Trial 2
(Date:12/1/2009)...released in the December 2009 issue of the Journa...r the survival improvement among patients with met... decades as reported in controlled clinical trials...00,000 patients with stage IV non-small cell lung ...e to evaluate trends in survival between 1990 and ...
(Date:12/1/2009)... The Centers for Disease Control (CD...States is born with an autism spectrum disorder. T...rove sensory processing by playing the new therape...m Vision Audio, Inc., a wonderful holiday gift ide... Joppa, MD (PRWEB) December 1, 2009 ...
(Date:12/1/2009)... , IRVINE, Calif., Dec. 1 /PRNewswire-Firs...of Pulse CO-Oximetry(TM) and Measure-Through Motio...d FDA clearance of its latest innovation -- Masimo...g noninvasive and continuous respiration rate (RRa...patient compliance. Masimo Rainbow SET Acoustic M...
(Date:12/1/2009)... Craig Moskowitz, a fourth-year medi... is choosing to go into internal medicine to help ...North Brunswick, NJ (PRWEB) December 1, 2009 -- Ha... US medical licensing examinations, Craig Moskowit...y School of Medicine--knew he could go into any ar...
(Date:12/1/2009)... Anthony M. Marlon, MD was elected t...emedica”) Board of Directors at the Company&... (PRWEB) December 1, 2009 -- Anthony ...echnologies , Inc. (“Stemedica”) Board... Board Meeting. Roger J. Howe, PhD, Executive Chai...
Breaking Medicine News(10 mins):Health News:EASe Funhouse Video Game Helps Children with Autism Learn to Improve Sensory Processing 2Health News:EASe Funhouse Video Game Helps Children with Autism Learn to Improve Sensory Processing 3Health News:EASe Funhouse Video Game Helps Children with Autism Learn to Improve Sensory Processing 4Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 2Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 3Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 4Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 5Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 6Health News:Trending Against the Norm: How One Top Scoring Ross University Medical Student is Choosing to Make a Difference in Internal Medicine 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 3
...ilable in French . , Montreal, January 22, 200...as demonstrated that preventive treatment with hig... reducing the severity and duration of asthma atta... professor at the Universit de Montral, led the st...
...ion, but some experts are skeptical , , TH...innish study casts doubts on the common assumption...p them thin. , Specifically, the researchers found...one more thing people should take into account whe...
...o serve as U.S. ambassador for unique diabetes cha...oncos quarterback Jay Cutler is reaching out to he... , Cutler -- who was diagnosed with type 1 diabete...ome an ambassador for Eli Lilly and Company,s Ins...
...ls valued at more than $3.0 Billion , , SYDNEY, A...a Limited (ASX: QRX and OTCQX: QRXPY), a clinical-...the development and commercialisation of therapies...iano brings more than 17 years of experience in he...
... - Engineers at Purdue and Stanford universities h...rdiac muscle cells, neurons and other cells react ...ic brain injuries and other diseases. , The devic...a Purdue associate professor of electrical and com...
... Peninsula Medical School, the University of Cambr...first time identified a relationship between Vitam...ment in a large-scale study of older people. The i...y to develop dementia. The paper will appear in a ...
Other Medicine News:Health News:New treatment reduces severity of asthma attacks in preschoolers 2Health News:Heavy Smoking as Teenager Might Add Pounds Later 2Health News:NFL Quarterback Jay Cutler to Help Families Affected by Diabetes by Joining Lilly's Inspired by Diabetes Campaign 2Health News:NFL Quarterback Jay Cutler to Help Families Affected by Diabetes by Joining Lilly's Inspired by Diabetes Campaign 3Health News:NFL Quarterback Jay Cutler to Help Families Affected by Diabetes by Joining Lilly's Inspired by Diabetes Campaign 4Health News:NFL Quarterback Jay Cutler to Help Families Affected by Diabetes by Joining Lilly's Inspired by Diabetes Campaign 5Health News:QRxPharma Expands Management Team with the Addition of Dr. Jesus Soriano as Executive Vice President 2Health News:QRxPharma Expands Management Team with the Addition of Dr. Jesus Soriano as Executive Vice President 3Health News:QRxPharma Expands Management Team with the Addition of Dr. Jesus Soriano as Executive Vice President 4Health News:New stretchable electrodes created to study stresses on cardiac cells 2Health News:'Sunshine vitamin' link to cognitive problems in older people 2
...its with hydrophobic PTFE membranes,Millex filter ...al for the sterilizing filtration of gases, for ve...r clarifying organic solutions. Ready-to-use steri...fferent outlet connections; other filter units can...
ArcticTemp Undercounter Refrigerator (5.2 Cubic Ft)
...its with hydrophobic PTFE membranes,Millex filter ...al for the sterilizing filtration of gases, for ve...r clarifying organic solutions. Ready-to-use steri...fferent outlet connections; other filter units can...
Undercounter Refrigerator
Medicine Products: